Variant report

Variant	esv3443711
Chromosome Location	chr2:208977244-208989245
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:94)
CpG islands
(count:488)
Chromatin interactive
region (count:2)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:94 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BRCA1	chr2:208977581-208978020	Hela-S3	cervix:	n/a	n/a
2	CEBPB	chr2:208984500-208984694	HepG2	liver:	n/a	chr2:208984649-208984660
3	CEBPB	chr2:208977669-208978022	Hela-S3	cervix:	n/a	n/a
4	CEBPB	chr2:208977579-208978082	MCF-7	breast:	n/a	n/a
5	CTCF	chr2:208980609-208980614	GM20000	blood:	n/a	n/a
6	CTCF	chr2:208977340-208977490	HEK293	kidney:	n/a	n/a
7	EBF1	chr2:208979727-208979939	GM12878	blood:	n/a	n/a
8	EBF1	chr2:208979719-208979944	GM12878	blood:	n/a	n/a
9	EP300	chr2:208989076-208989430	H1-hESC	embryonic stem cell:	n/a	chr2:208989351-208989365 chr2:208989353-208989367
10	EP300	chr2:208977697-208978032	Hela-S3	cervix:	n/a	n/a
11	FOXA1	chr2:208981635-208981884	HepG2	liver:	n/a	n/a
12	FOXA1	chr2:208977665-208977947	T-47D	breast:	n/a	chr2:208977821-208977836
13	FOXA1	chr2:208977687-208978007	T-47D	breast:	n/a	chr2:208977821-208977836
14	FOXA2	chr2:208981605-208981868	HepG2	liver:	n/a	n/a
15	GATA2	chr2:208977776-208978015	SH-SY5Y	brain:	n/a	chr2:208977894-208977901
16	GATA2	chr2:208982079-208982439	K562	blood:	n/a	n/a
17	GATA3	chr2:208977479-208978321	MCF-7	breast:	n/a	chr2:208977894-208977901
18	GATA3	chr2:208977683-208978104	MCF-7	breast:	n/a	chr2:208977894-208977901
19	GATA3	chr2:208977691-208977969	MCF-7	breast:	n/a	chr2:208977894-208977901
20	GATA3	chr2:208977672-208978004	T-47D	breast:	n/a	chr2:208977894-208977901
21	GATA3	chr2:208977518-208978320	MCF-7	breast:	n/a	chr2:208977894-208977901
22	GATA3	chr2:208977680-208977997	T-47D	breast:	n/a	chr2:208977894-208977901
23	GTF2F1	chr2:208977428-208977977	H1-hESC	embryonic stem cell:	n/a	n/a
24	HDAC2	chr2:208977563-208978158	MCF-7	breast:	n/a	n/a
25	HDAC2	chr2:208977673-208978123	MCF-7	breast:	n/a	n/a
26	IRF1	chr2:208977828-208977969	K562	blood:	n/a	n/a
27	JUND	chr2:208977914-208978040	H1-hESC	embryonic stem cell:	n/a	n/a
28	JUND	chr2:208986075-208986320	HepG2	liver:	n/a	n/a
29	KAP1	chr2:208977537-208978187	U2OS	brain:	n/a	n/a
30	KAP1	chr2:208977575-208978211	HEK293	kidney:	n/a	n/a
31	MAX	chr2:208977641-208978157	MCF-7	breast:	n/a	n/a
32	MAX	chr2:208977552-208978187	MCF-7	breast:	n/a	n/a
33	MAX	chr2:208977703-208978076	Hela-S3	cervix:	n/a	n/a
34	MAX	chr2:208989020-208989338	H1-hESC	embryonic stem cell:	n/a	n/a
35	MAX	chr2:208977636-208978123	H1-hESC	embryonic stem cell:	n/a	n/a
36	MAX	chr2:208977635-208978076	Hela-S3	cervix:	n/a	n/a
37	MAZ	chr2:208977734-208978110	Hela-S3	cervix:	n/a	n/a
38	MYC	chr2:208977803-208977816	Hela-S3	cervix:	n/a	n/a
39	MYC	chr2:208988856-208989006	MCF-7	breast:	n/a	n/a
40	NR2F2	chr2:208977559-208978214	MCF-7	breast:	n/a	n/a
41	NR2F2	chr2:208982125-208982427	K562	blood:	n/a	n/a
42	POLR2A	chr2:208978010-208978071	Hela-S3	cervix:	n/a	n/a
43	POLR2A	chr2:208976929-208977331	H1-hESC	embryonic stem cell:	n/a	n/a
44	POLR2A	chr2:208977789-208978102	H1-hESC	embryonic stem cell:	n/a	n/a
45	POLR2A	chr2:208986477-208986515	MCF-7	breast:	n/a	n/a
46	POLR2A	chr2:208989191-208989274	H1-hESC	embryonic stem cell:	n/a	n/a
47	POLR2A	chr2:208988949-208988966	Gliobla	brain:	n/a	n/a
48	POLR2A	chr2:208988757-208989235	H1-hESC	embryonic stem cell:	n/a	n/a
49	POLR2A	chr2:208986521-208986549	MCF-7	breast:	n/a	n/a
50	POLR2A	chr2:208988808-208989036	MCF-7	breast:	n/a	n/a

(count:488 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:208977452-208977502	SK-N-MC	brain:	n/a
2	chr2:208989209-208989259	MCF-7	breast:	n/a
3	chr2:208977452-208977502	NT2-D1	testis:	n/a
4	chr2:208977395-208977445	AoSMC	blood vessel:	n/a
5	chr2:208988453-208988503	HEK293	kidney:	embryo
6	chr2:208989209-208989259	AG04450	lung:	fetal
7	chr2:208977395-208977445	Jurkat	blood:	n/a
8	chr2:208977395-208977445	HIPEpiC	eye:	n/a
9	chr2:208977395-208977445	HNPCEpiC	eye:	n/a
10	chr2:208988932-208988982	HIPEpiC	eye:	n/a
11	chr2:208988863-208988913	SAEC	small airway:	n/a
12	chr2:208988453-208988503	HRCEpiC	kidney:	n/a
13	chr2:208988932-208988982	SK-N-MC	brain:	n/a
14	chr2:208977395-208977445	NHBE	bronchial:	n/a
15	chr2:208988967-208989017	HMEC	breast:	n/a
16	chr2:208988967-208989017	ProgFib	skin:	n/a
17	chr2:208988967-208989017	HIPEpiC	eye:	n/a
18	chr2:208986497-208986547	U87	brain:	n/a
19	chr2:208977452-208977502	HCM	heart:	n/a
20	chr2:208988932-208988982	NT2-D1	testis:	n/a
21	chr2:208988932-208988982	HUVEC	blood vessel:	n/a
22	chr2:208986497-208986547	T-47D	breast:	n/a
23	chr2:208988453-208988503	ProgFib	skin:	n/a
24	chr2:208977395-208977445	HepG2	liver:	n/a
25	chr2:208977395-208977445	LNCaP	prostate:	n/a
26	chr2:208989209-208989259	HCM	heart:	n/a
27	chr2:208988932-208988982	HEK293	kidney:	embryo
28	chr2:208977452-208977502	Hepatocyte	liver:	n/a
29	chr2:208988932-208988982	NHDF-neo	bronchial:	n/a
30	chr2:208988967-208989017	HRE	kidney:	n/a
31	chr2:208988863-208988913	HNPCEpiC	eye:	n/a
32	chr2:208988932-208988982	MCF10A-Er-Src	breast:	n/a
33	chr2:208988863-208988913	HEK293	kidney:	embryo
34	chr2:208977395-208977445	NHDF-neo	bronchial:	n/a
35	chr2:208986497-208986547	Hepatocyte	liver:	n/a
36	chr2:208988453-208988503	AG10803	skin:	n/a
37	chr2:208977452-208977502	HAEpiC	amniotic membrane:	n/a
38	chr2:208988453-208988503	H1-hESC	embryonic stem cell:	embryo
39	chr2:208988453-208988503	NHBE	bronchial:	n/a
40	chr2:208988967-208989017	BJ	skin:	n/a
41	chr2:208989209-208989259	GM12878	blood:	n/a
42	chr2:208989209-208989259	SK-N-SH	brain:	n/a
43	chr2:208986497-208986547	SKMC	muscle:	n/a
44	chr2:208988863-208988913	HAEpiC	amniotic membrane:	n/a
45	chr2:208988967-208989017	AoSMC	blood vessel:	n/a
46	chr2:208977452-208977502	T-47D	breast:	n/a
47	chr2:208977395-208977445	PFSK-1	brain:	n/a
48	chr2:208988932-208988982	HAEpiC	amniotic membrane:	n/a
49	chr2:208986497-208986547	Caco-2	colon:	n/a
50	chr2:208988967-208989017	ECC-1	luminal epithelium:	n/a

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr2:208973001..208975909-chr2:208979754..208981880,3	MCF-7	breast:
2	chr2:208989109..208991585-chr2:208994453..208996077,2	K562	blood:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-PIKFYVE-4	chr2:208983830-208983949	NONHSAT076631
2	lnc-PIKFYVE-4	chr2:208983830-208983949	NONHSAT076630
3	lnc-PIKFYVE-4	chr2:208983853-208983949	NONHSAT076632

No data

Variant related genes	Relation type
CRYGD	TF binding region
CRYGEP	TF binding region
CRYGD	CpG island
CRYGEP	CpG island
ENSG00000163254	chromatin interactions

Extended variants
information (count: 515 )
Associated
traits (count: 53 )

Variant overlapped rSNPs/rCNVs (count:515 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs34532696	chr2:208977255-208977256	Active TSS Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs375525091	chr2:208977257-208977258	Active TSS Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs377692565	chr2:208977261-208977262	Active TSS Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs572842283	chr2:208977264-208977265	Active TSS Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs368761488	chr2:208977314-208977315	Active TSS Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs529953502	chr2:208977315-208977316	Active TSS Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs545134826	chr2:208977317-208977318	Active TSS Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs558638404	chr2:208977320-208977321	Active TSS Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs11679871	chr2:208977323-208977324	Active TSS Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs544781703	chr2:208977327-208977328	Active TSS Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs561456479	chr2:208977328-208977329	Active TSS Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs530396457	chr2:208977346-208977347	Active TSS Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs34126491	chr2:208977362-208977363	Active TSS Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs560127526	chr2:208977384-208977385	Active TSS Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs11679917	chr2:208977388-208977389	Active TSS Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs552302663	chr2:208977396-208977397	Active TSS Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
17	rs55999272	chr2:208977402-208977403	Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs530654142	chr2:208977438-208977439	Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
19	rs543235043	chr2:208977477-208977478	Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
20	rs192881353	chr2:208977478-208977479	Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
21	rs115533419	chr2:208977479-208977480	Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
22	rs11679982	chr2:208977514-208977515	Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs546876583	chr2:208977519-208977520	Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs73983700	chr2:208977528-208977529	Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs184934844	chr2:208977537-208977538	Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs188270759	chr2:208977549-208977550	Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs73983701	chr2:208977550-208977551	Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
28	rs561525568	chr2:208977584-208977585	Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs538082815	chr2:208977613-208977614	Flanking Active TSS Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs147467354	chr2:208977627-208977628	Flanking Active TSS Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs574898511	chr2:208977706-208977707	Flanking Active TSS Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs180886562	chr2:208977723-208977724	Flanking Active TSS Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs73983702	chr2:208977763-208977764	Flanking Active TSS Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs528804999	chr2:208977786-208977787	Flanking Active TSS Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs10497893	chr2:208977797-208977798	Flanking Active TSS Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs186299191	chr2:208977803-208977804	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs562871652	chr2:208977812-208977813	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs73986503	chr2:208977825-208977826	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
39	rs189518297	chr2:208977845-208977846	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs561146018	chr2:208977873-208977874	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs529869480	chr2:208977874-208977875	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs139854512	chr2:208977906-208977907	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs566762963	chr2:208977911-208977912	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs73986504	chr2:208977940-208977941	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs142770741	chr2:208977950-208977951	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs62192824	chr2:208977960-208977961	Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs6731578	chr2:208978010-208978011	Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs537958375	chr2:208978078-208978079	Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs554324636	chr2:208978108-208978109	Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs558204468	chr2:208978121-208978122	Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:53)

Disease	PMID	Source
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Ependymoma	16718352	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Testicular germ cell tumor	18059402	CNVD
Breast cancer	16272173	CNVD
Ewing''s sarcoma	17952124	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
Colorectal cancer	16272173	CNVD
Lung cancer	18438408	CNVD
Glioblastoma	21080181	CNVD
Prostate cancer	18632612	CNVD
Acute myeloid leukemia	20729466	CNVD
small cell lung cancer	20016488	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Urothelial carcinoma	21177765	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Papillary thyroid carcinoma	22161024	CNVD
Cervical cancer	21062161	CNVD
Intracranial aneurysm	16715129	CNVD
Hepatocellular carcinoma	16750200	CNVD
Prostate cancer	16573809	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Glioblastoma multiforme	22286061	CNVD
Non-muscle invasive bladder neoplasm	19445696	CNVD
Myelofibrosis	22110671	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Non-small cell lung cancer	21829676	CNVD
Autism	20808228	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:222 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:208973200-208989000	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
2	chr2:208976200-208977600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
3	chr2:208976600-208977400	Active TSS	H9 Cell Line	embryonic stem cell
4	chr2:208976600-208978000	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
5	chr2:208976800-208977400	Active TSS	HUES64 Cell Line	embryonic stem cell
6	chr2:208976800-208977400	Active TSS	iPS-18 Cell Line	embryonic stem cell
7	chr2:208976800-208977400	Active TSS	iPS-20b Cell Line	embryonic stem cell
8	chr2:208976800-208977600	Active TSS	ES-I3 Cell Line	embryonic stem cell
9	chr2:208976800-208977600	Active TSS	iPS-15b Cell Line	embryonic stem cell
10	chr2:208976800-208977600	Flanking Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
11	chr2:208977000-208977400	Bivalent Enhancer	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
12	chr2:208977000-208977400	Bivalent/Poised TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
13	chr2:208977000-208977400	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
14	chr2:208977000-208977400	Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
15	chr2:208977000-208977400	Bivalent/Poised TSS	Brain Germinal Matrix	brain
16	chr2:208977000-208977600	Active TSS	HUES6 Cell Line	embryonic stem cell
17	chr2:208977000-208977600	Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
18	chr2:208977000-208977600	Bivalent/Poised TSS	Brain Hippocampus Middle	brain
19	chr2:208977000-208977600	Active TSS	Right Atrium	heart
20	chr2:208977000-208977800	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
21	chr2:208977200-208977400	Flanking Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
22	chr2:208977200-208977400	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
23	chr2:208977200-208977400	Bivalent/Poised TSS	Adipose Nuclei	Adipose
24	chr2:208977200-208977400	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
25	chr2:208977200-208977400	Bivalent Enhancer	Left Ventricle	heart
26	chr2:208977200-208977400	Flanking Active TSS	Ovary	ovary
27	chr2:208977200-208977400	Enhancers	Right Ventricle	heart
28	chr2:208977200-208977600	Flanking Active TSS	Cortex derived primary cultured neurospheres	brain
29	chr2:208977200-208977600	Bivalent/Poised TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
30	chr2:208977200-208977600	Bivalent Enhancer	Fetal Brain Male	brain
31	chr2:208977200-208977600	Active TSS	Fetal Brain Female	brain
32	chr2:208977200-208977800	Active TSS	ES-WA7 Cell Line	embryonic stem cell
33	chr2:208977200-208977800	Bivalent Enhancer	Fetal Lung	lung
34	chr2:208977200-208978000	Active TSS	H1 Cell Line	embryonic stem cell
35	chr2:208977200-208978000	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
36	chr2:208977200-208978000	Enhancers	Gastric	stomach
37	chr2:208977200-208978600	Enhancers	HUES48 Cell Line	embryonic stem cell
38	chr2:208977400-208977600	Flanking Bivalent TSS/Enh	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
39	chr2:208977400-208977600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
40	chr2:208977400-208977600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
41	chr2:208977400-208977600	Bivalent Enhancer	Adipose Nuclei	Adipose
42	chr2:208977400-208977600	Flanking Bivalent TSS/Enh	Brain Germinal Matrix	brain
43	chr2:208977400-208977600	Active TSS	Ovary	ovary
44	chr2:208977400-208978000	Weak transcription	H9 Cell Line	embryonic stem cell
45	chr2:208977400-208978000	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
46	chr2:208977400-208978000	Enhancers	Placenta Amnion	Placenta Amnion
47	chr2:208977400-208978200	Enhancers	Fetal Intestine Small	intestine
48	chr2:208977400-208978400	Flanking Active TSS	HUES64 Cell Line	embryonic stem cell
49	chr2:208977400-208978600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
50	chr2:208977400-208978600	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links